veterinary medical research during his distinguished career, including experimental investigations on lead poisoning in young dogs that helped establish the diagnostic criteria for confirmation of canine lead poisoning. His main research interest was in diseases and pathologic conditions that exert an influence on the central nervous system of animals. Between 1985 and 1995, while he was at University of Pennsylvania, he collaborated with Dr Charles E. Rupprecht and Dr Cathleen A. Hanlon in the experimental evaluation of the safety and efficacy, as well as extensive field testing of a then novel genetically engineered vaccinia-rabies glycoprotein (V-RG) oral rabies vaccine for raccoons and nontarget species. This vaccine is widely used today in the control of rabies in selected wildlife populations. Much of Dr Hamir's research focused on diseases of indigenous wild animals. In 1998, Dr Hamir joined the National Animal Disease Center in Ames, Iowa (part of the USDA's Agricultural Research Service), where he helped complete and lead a series of long-term interspecies prion disease transmission studies through 2009. These important studies contributed significantly to our understanding of an apparent natural species barrier of cattle to chronic wasting disease of cervids and scrapie of sheep. During his tenure at the National Animal Disease Center, Dr Hamir provided mentorship and assistance to several new scientists in the prion disease research group. In 2009, Dr Hamir joined the Department of Veterinary Medicine & Surgery at The University of Texas M. D. Anderson Cancer Center in Houston, Texas, as a Professor, where he continued his pathology research. This move brought him geographically closer to his family and, in particular, his grandchildren. Amir Hamir is survived by his wife, Almas; 2 sons (Zubair and Akraad); and 2 daughters-in-law (Heather and Liz). Zubair and Heather are parents of Amir's 2 grandchildren, who were sources of great joy for him. 
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